The development of targeted therapies involves several stages:
Identifying Targets: Researchers first identify specific genes or proteins that play a critical role in cancer cell growth. Drug Development: Once a target is identified, potential drugs are synthesized and tested in preclinical studies to assess their efficacy and safety. Clinical Trials: Promising drug candidates go through clinical trials to evaluate their performance in humans. These trials are conducted in several phases to ensure safety and effectiveness. Regulatory Approval: If successful, the drug is submitted for approval by regulatory bodies like the FDA, allowing it to be marketed and prescribed to patients.
